Can Percutaneous Coronary Interventions Reduce Death and Myocardial Infarction in Stable and Unstable Coronary Disease?

Patricia Best, Peter B. Berger

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

In the high-risk patients such as those with an MI or cardiogenic shock, PCI clearly reduces mortality. Since PCI provides greater coronary artery patency than thrombolytic therapy with a lower risk of stroke, it is not surprising that PCI is of greater benefit to these patients when it is available. Furthermore, in patients after an MI with ischemia or angina, revascularization by a percutaneous or surgical approach is associated with a reduction in subsequent MIs. In patients with multivessel disease, including those with high-risk anatomy such as three-vessel disease and reduced ventricular function, survival appears to be as good with PCI as with CABG in patients suitable for both procedures. In patients with stable coronary disease, low-risk patients will do well without PCI on medical therapy alone. In high-risk patients with stable coronary disease such as those with poor exercise tolerance and more severe angina, PCI can clearly improve exercise duration and anginal symptoms. Moreover, in patients with multivessel disease, particularly nondiabetic patients with multivessel disease, survival is similar with PCI and CABG.

Original languageEnglish (US)
Pages (from-to)528-536
Number of pages9
JournalCatheterization and Cardiovascular Interventions
Volume61
Issue number4
DOIs
StatePublished - Apr 1 2004

Fingerprint

Percutaneous Coronary Intervention
Coronary Disease
Myocardial Infarction
Exercise Tolerance
Survival
Ventricular Function
Cardiogenic Shock
Thrombolytic Therapy
Anatomy
Coronary Vessels
Ischemia
Stroke
Exercise
Mortality

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Can Percutaneous Coronary Interventions Reduce Death and Myocardial Infarction in Stable and Unstable Coronary Disease? / Best, Patricia; Berger, Peter B.

In: Catheterization and Cardiovascular Interventions, Vol. 61, No. 4, 01.04.2004, p. 528-536.

Research output: Contribution to journalReview article

@article{32a8052ca583488ab8b0fd06f3a2edc9,
title = "Can Percutaneous Coronary Interventions Reduce Death and Myocardial Infarction in Stable and Unstable Coronary Disease?",
abstract = "In the high-risk patients such as those with an MI or cardiogenic shock, PCI clearly reduces mortality. Since PCI provides greater coronary artery patency than thrombolytic therapy with a lower risk of stroke, it is not surprising that PCI is of greater benefit to these patients when it is available. Furthermore, in patients after an MI with ischemia or angina, revascularization by a percutaneous or surgical approach is associated with a reduction in subsequent MIs. In patients with multivessel disease, including those with high-risk anatomy such as three-vessel disease and reduced ventricular function, survival appears to be as good with PCI as with CABG in patients suitable for both procedures. In patients with stable coronary disease, low-risk patients will do well without PCI on medical therapy alone. In high-risk patients with stable coronary disease such as those with poor exercise tolerance and more severe angina, PCI can clearly improve exercise duration and anginal symptoms. Moreover, in patients with multivessel disease, particularly nondiabetic patients with multivessel disease, survival is similar with PCI and CABG.",
author = "Patricia Best and Berger, {Peter B.}",
year = "2004",
month = "4",
day = "1",
doi = "10.1002/ccd.20016",
language = "English (US)",
volume = "61",
pages = "528--536",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Can Percutaneous Coronary Interventions Reduce Death and Myocardial Infarction in Stable and Unstable Coronary Disease?

AU - Best, Patricia

AU - Berger, Peter B.

PY - 2004/4/1

Y1 - 2004/4/1

N2 - In the high-risk patients such as those with an MI or cardiogenic shock, PCI clearly reduces mortality. Since PCI provides greater coronary artery patency than thrombolytic therapy with a lower risk of stroke, it is not surprising that PCI is of greater benefit to these patients when it is available. Furthermore, in patients after an MI with ischemia or angina, revascularization by a percutaneous or surgical approach is associated with a reduction in subsequent MIs. In patients with multivessel disease, including those with high-risk anatomy such as three-vessel disease and reduced ventricular function, survival appears to be as good with PCI as with CABG in patients suitable for both procedures. In patients with stable coronary disease, low-risk patients will do well without PCI on medical therapy alone. In high-risk patients with stable coronary disease such as those with poor exercise tolerance and more severe angina, PCI can clearly improve exercise duration and anginal symptoms. Moreover, in patients with multivessel disease, particularly nondiabetic patients with multivessel disease, survival is similar with PCI and CABG.

AB - In the high-risk patients such as those with an MI or cardiogenic shock, PCI clearly reduces mortality. Since PCI provides greater coronary artery patency than thrombolytic therapy with a lower risk of stroke, it is not surprising that PCI is of greater benefit to these patients when it is available. Furthermore, in patients after an MI with ischemia or angina, revascularization by a percutaneous or surgical approach is associated with a reduction in subsequent MIs. In patients with multivessel disease, including those with high-risk anatomy such as three-vessel disease and reduced ventricular function, survival appears to be as good with PCI as with CABG in patients suitable for both procedures. In patients with stable coronary disease, low-risk patients will do well without PCI on medical therapy alone. In high-risk patients with stable coronary disease such as those with poor exercise tolerance and more severe angina, PCI can clearly improve exercise duration and anginal symptoms. Moreover, in patients with multivessel disease, particularly nondiabetic patients with multivessel disease, survival is similar with PCI and CABG.

UR - http://www.scopus.com/inward/record.url?scp=1842427484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842427484&partnerID=8YFLogxK

U2 - 10.1002/ccd.20016

DO - 10.1002/ccd.20016

M3 - Review article

C2 - 15065151

AN - SCOPUS:1842427484

VL - 61

SP - 528

EP - 536

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 4

ER -